Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

Pharma deals during July 2014

Pharma deals during July 2014 AZ will also acquire Almirall Sofotec, Almirall's inhalation device business which includes Genuair, its novel multi-dose dry powder inhalation (DPI) device. ... Almirall will receive $875m upfront and up to $1.22bn in development, launch, and

FDA approves Boehringer COPD spray Striverdi Respimat

FDA approves Boehringer COPD spray Striverdi Respimat Meanwhile Almirall, whose respiratory franchise is to be bought by AstraZeneca in a $2bn deal, has its own COPD combination - aclidinium bromide/formoterol candidate - in phase III with Forest Labs.

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio Commenting on the Almirall deal Soriot said: “We will benefit from immediate and growing product revenues which we anticipate will be rapidly accretive to earnings. ... Almirall president Jorge Gallardo said the AZ deal would “better develop our

GSK trial throws everything at COPD

GSK trial throws everything at COPD Meanwhile, and Forest Labs/Almirall are all bringing their own LAMA/LABA combinations through the pipeline, so GSK's triple therapy approach could help it stay ahead of the pack.

GSK's Anoro backed in Europe for COPD

GSK's Anoro backed in Europe for COPD and Forest Labs/Almirall are also bringing their own LAMA/LABA combinations through development.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics